DLco simulations for qualification of DLco devices globally for inhaled levodopa clinical trials.

J. Blonshine (Mason, United States of America), S. Blonshine (Mason, United States of America)

Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Session: Quality, performance and interpretation of lung function testing
Session type: Thematic Poster
Number: 1133

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Blonshine (Mason, United States of America), S. Blonshine (Mason, United States of America). DLco simulations for qualification of DLco devices globally for inhaled levodopa clinical trials.. 1133

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: